Back to Intelligence

#pharmaceutical-supply-chain

(10 articles)
Sustainability & ESG
ModerateOct 19, 2026

Pharma Shipper Cuts Dry Ice Use with Data-Led Sustainable Packaging

Cold Chain Technologies has successfully redesigned a global biopharmaceutical customer's temperature-controlled shipping strategy by replacing dry ice-based systems with a data-driven packaging solut

Manufacturing Chemist#cold-chain-packaging#pharma-logistics#sustainable-shipping
Risk & Disruption
High ImpactSep 18, 2026

Geopolitics Reshapes Pharma Packaging Security Strategy

Pharmaceutical packaging has become a critical vulnerability in global supply chains as geopolitical tensions create uncertainty in sourcing and regulatory compliance. The article examines how trade r

Express Pharma#pharma-packaging#geopolitical-risk#supply-chain-security
Risk & Disruption
High ImpactAug 29, 2026

Pharma Supply Chain Faces Global Disruption: BCG-Dentons 2026

Boston Consulting Group and Dentons have jointly released an in-depth analysis examining structural vulnerabilities and emerging disruptions across the global pharmaceutical and life sciences supply c

Klover.ai#pharmaceutical-supply-chain#global-disruption#life-sciences-logistics
Risk & Disruption
High ImpactAug 25, 2026

Pharma Supply Chains Face Critical Vulnerabilities Amid Iran Tensions

The NATO Association analysis reveals that global pharmaceutical supply chains harbor significant structural vulnerabilities that geopolitical conflicts, particularly tensions with Iran, can rapidly e

NATO Association#pharmaceutical-supply-chain#geopolitical-risk#iran-conflict
Trade Policy & Tariffs
High ImpactAug 20, 2026

Trump's 2028 Generic Drug Tariff Proposal: Supply Chain Implications

The Trump administration's proposed tariff on generic drugs targeting 2028 represents a significant policy shift that could reshape pharmaceutical supply chains and pricing dynamics. While framed as a

Vinanet#generic-drug-tariffs#trade-policy#pharmaceutical-supply-chain
Risk & Disruption
ModerateAug 4, 2026

Pharma Supply Chains: Beyond Price to Resilience Metrics

The pharmaceutical industry is undergoing a fundamental shift in how supply chains are evaluated and managed. Rather than optimizing solely for procurement costs, leading pharma companies are adopting

Pharmaceutical Commerce#pharmaceutical-supply-chain#supply-chain-resilience#drug-distribution
Trade Policy & Tariffs
High ImpactAug 4, 2026

Trump's Generic Drug Tariffs Threaten Medicine Prices and Supply

The Trump administration's proposal to impose tariffs on generic drugs represents a significant structural shift in how the US pharmaceutical supply chain operates. Generic drugs, which represent roug

CNBC#generic-drug-tariffs#pharmaceutical-supply-chain#trump-trade-policy
Risk & Disruption
High ImpactAug 3, 2026

Air Cargo Delays Put Patient Treatment at Risk

Air cargo delays have escalated beyond operational inconvenience to become a patient safety and healthcare delivery issue. When pharmaceutical shipments, medical devices, and temperature-sensitive tre

Air Cargo Week#air-cargo-delays#pharmaceutical-supply-chain#healthcare-logistics
Trade Policy & Tariffs
High ImpactJul 26, 2026

Iran Conflict Threatens Global Pharmaceutical Supply Chains

A conflict involving Iran poses significant risk to global pharmaceutical supply chains due to the region's strategic importance in drug manufacturing and trade routes. Iran and neighboring countries

Think Global Health#iran-conflict#pharmaceutical-supply-chain#geopolitical-risk
Risk & Disruption
High ImpactJul 19, 2026

100 Essential US Medicines Face Hidden Supply Chain Risks

A comprehensive CIDRAP analysis has identified hidden supply chain vulnerabilities affecting approximately 100 essential medicines in the United States. These risks stem from single-source dependencie

CIDRAP#pharmaceutical-supply-chain#medicine-shortage-risk#supply-chain-resilience